Review papers with raw data transparency

Key reported results (paper-provided)

• Dataset: 534,689 FACS-sorted neutrophils profiled by scRNA-seq across multiple mouse disease models and tissues (bone marrow, blood, spleen, diseased tissues) Paper dataset and availability
• Two reproducible disease-associated neutrophil clusters: (A) tissue-enriched Cd274+/Vegfa+/MHCII+ (Neu_Ccl4/Neu_MHCII/Neu_Acod1) and (B) peripheral Cd244+/Il4ra+ immature/type-2-response (Neu_Cd244a) Two neutrophil clusters described
• Mechanistic perturbations: IFN (lymphocyte-derived) required for full Cd274+ induction (Ifngr1-/- and lymphocyte-deficient mice show reduced Cd274+ neutrophils); TNF/IFNs sufficient in vitro to induce Cd274 expression in BM neutrophils (bulk RNA-seq + FACS) IFN dependency for Cd274+ induction

Strengths / Why this matters

• Scale and breadth — exceptionally large neutrophil single-cell dataset across >6 disease models and multiple tissues; raw/processed data openly available (enables independent re-analysis) Data availability
• Multiple orthogonal validations — FACS protein-level confirmation, in vitro cytokine stimulations, bulk RNA-seq of sorted populations, and genetic mouse models supporting the inferred regulatory role of IFNs for the Cd274+ state Experimental validations

Limitations, blindspots, and alternative interpretations

• Mouse-only: Findings in murine models may not directly translate to human neutrophil biology or clinical diagnostics; human datasets and functional validation are required before clinical extrapolation (typical neutrophil heterogeneity across species is documented) Mouse model limitation
• Functional causality incomplete: While IFN involvement is supported, the downstream functional consequences of Neu_MHCII or Neu_Ccl4 in vivo (antigen presentation, pro- vs anti-tumor action, angiogenesis via Vegfa) need rigorous loss/gain-of-function tests targeted to neutrophils (conditional knockouts, lineage tracing, in vivo antigen-presentation assays) Functional depth missing
• Quantitative transparency: The processed h5ad is available, but key summary numeric tables (per-cluster counts by tissue/model in main figures) could be clearer to allow faster replication without downloading large files; batch-correction and integration steps are described but full parameter choices (e.g., Scanpy/Seurat versions, integration anchors, random seeds) should be explicit for perfect reproducibility Reproducibility nuance
• Possible confounders: Disease models differ in systemic inflammation, immune cell composition, mouse strain, age, tumor immunogenicity, and sampling timepoints; some clusters may arise from model-specific timing or neutrophil maturation-state shifts rather than shared disease biology (authors partially address this by multi-model sampling but residual confounding is possible) Confounding by model/tissue

Evidence weight — how confident are the claims?

• Existence of two major clusters: high confidence — derived from large n, cross-model detection, and FACS/bulk validation (strong support) Cluster reproducibility
• IFN control of Cd274+ tissue cluster: moderate-to-high confidence — supported by in vitro cytokine treatment, Ifngr1 knockout, and lymphocyte-deficient mice, but requires cell-specific manipulations to claim cell-intrinsic vs paracrine effects (moderate evidence) IFN linkage evidence
• Functional immunosuppression by Cd244+ neutrophils: preliminary evidence — in vitro co-culture shows induction of Tim3/Lag3 on CD8 T cells and anti-Cd244 antibody increased lung cytokines in ALI, suggesting immunomodulatory role but in vivo neutrophil-specific causal proof remains missing (moderate-to-weak evidence) Cd244 immunosuppression evidence

Concrete next experiments to strengthen/extend the manuscript

1. Neutrophil-specific conditional Ifngr1 deletion (Mrp8-Cre or Ly6G-Cre lines) to test cell-intrinsic IFN requirement for Neu_Ccl4 induction in vivo; measure Cd274, Vegfa, MHCII expression, and functional readouts (tumor growth, lung injury severity) — would falsify/confirm lymphocyte-IFN→neutrophil pathway.
2. Adoptive transfer of sorted Neu_MHCII or Neu_Ccl4 neutrophils into neutrophil-depleted hosts in tumor and ALI models to test sufficiency for immunosuppression or angiogenesis in vivo (endpoints: tumor size, CD8 T cell function, vessel density via CD31 imaging).
3. Cross-species comparison: analyze available human tumor and inflammatory-disease scRNA/bulk datasets for Cd274/Vegfa/MHCII and Cd244/Il4ra neutrophil signatures (authors' processed h5ad facilitates building gene modules) to evaluate translational relevance.
4. Temporal dynamics: lineage-tracing or barcoding to determine whether Neu_Cd244a represents an arrested/immature state that can convert to Neu_Ccl4/Neu_MHCII upon tissue entry, or whether these are distinct lineages.

Figures & Data access

Raw and processed data locations (download to reproduce all plots):

• Genome Sequence Archive accession CRA020963 (raw FASTQ) — available for download and independent alignment/processing CRA020963 (GSA)
• Figshare processed h5ad with cell metadata, UMAP coords, and gene annotations — recommended first stop to reproduce UMAPs/cluster markers without reprocessing FASTQ Figshare processed h5ad